Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease-Reference-Cited by-同舟云学术

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

Published:2015-08-05 Issue:9 Volume:85 Page:790-798
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Wang Fen,Gordon Brian A.,Ryman Davis C.,Ma Shengmei,Xiong Chengjie,Hassenstab Jason,Goate Alison,Fagan Anne M.,Cairns Nigel J.,Marcus Daniel S.,McDade Eric,Ringman John M.,Graff-Radford Neill R.,Ghetti Bernardino,Farlow Martin R.,Sperling Reisa,Salloway Steve,Schofield Peter R.,Masters Colin L.,Martins Ralph N.,Rossor Martin N.,Jucker Mathias,Danek Adrian,Förster Stefan,Lane Christopher A.S.,Morris John C.,Benzinger Tammie L.S.,Bateman Randall J.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference40 articles.

1. Alzheimer's Disease: The Amyloid Cascade Hypothesis

2. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

3. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

4. Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

5. Early A accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

2. Intracerebral inoculation of healthy non-transgenic rats with a single aliquot of oligomeric amyloid-β (1–42) profoundly and progressively alters brain function throughout life;Frontiers in Aging Neuroscience;2024-08-02

3. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer’s Disease;Molecular Neurobiology;2023-10-13

4. A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease;Alzheimer's Research & Therapy;2023-05-02

5. Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease;Alzheimer's Research & Therapy;2022-04-20